SEARCH News

Please select news category and type keyword(s) to search

Category of News All English Malay Road to Wellness

Vivantis Technologies Hasilkan Kit Ujian COVID-19, Penyelesaian Krisis Semasa

Oleh Nadia Jumri

KUALA LUMPUR (Bernama) -- Percaya atau tidak, sudah kira-kira setahun dunia bertungkus-lumus berusaha memerangi COVID-19 yang telah menjejaskan lebih 200 negara dan wilayah.

Di Malaysia, gelombang ketiga jangkitan virus itu telah meningkatkan jumlah kes kepada lebih 70,000 orang. Manakala di seluruh dunia pula virus itu menjangkiti kira-kira 65 juta orang dan menyebabkan 1.5 juta kematian.

Memandangkan virus ini sangat berbahaya, usaha menghasilkan kit ujian COVID-19 menjadi  keutamaan kepada syarikat bioteknologi tertentu yang bertanggungjawab dalam penyelidikan dan pembangunan (R&D) di Malaysia.

Vivantis Technologies Hasilkan Kit Ujian COVID-19, Penyelesaian Krisis Semasa

Oleh Nadia Jumri

KUALA LUMPUR (Bernama) -- Percaya atau tidak, sudah kira-kira setahun dunia bertungkus-lumus berusaha memerangi COVID-19 yang telah menjejaskan lebih 200 negara dan wilayah.

Di Malaysia, gelombang ketiga jangkitan virus itu telah meningkatkan jumlah kes kepada lebih 70,000 orang. Manakala di seluruh dunia pula virus itu menjangkiti kira-kira 65 juta orang dan menyebabkan 1.5 juta kematian.

Memandangkan virus ini sangat berbahaya, usaha menghasilkan kit ujian COVID-19 menjadi  keutamaan kepada syarikat bioteknologi tertentu yang bertanggungjawab dalam penyelidikan dan pembangunan (R&D) di Malaysia.

Vivantis Technologies Elevates COVID-19 Testing Capacity In Malaysia

By Nadia Jumri

KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.

In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.

Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.

Vivantis Technologies Elevates COVID-19 Testing Capacity In Malaysia

By Nadia Jumri

KUALA LUMPUR (Bernama) – The world has been battling COVID-19 for close to a year now, with more than 200 countries and territories affected by the pandemic.

In Malaysia, the third wave of infections led to total case numbers spiking to over 75,000. Globally, the virus has infected more than 68 million people and caused over 1.5 million fatalities.

Due to the virus’ highly virulent nature, producing COVID-19 test kits has become a top priority for certain biotechnology companies focusing on research and development (R&D) in Malaysia.

COVID-19: Empat Kluster Baharu, Kes Aktif Meningkat 196

Oleh Melati Mohd Ariff

Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 8 Ogos hingga pukul 7:30 mlm 14 Ogos.

Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 20 juta dengan lebih 700,000 kematian. Lebih 14 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.

KUALA LUMPUR (Bernama) -- Kes baharu COVID-19 sepanjang rangkuman mingguan ini banyak melibatkan kes import iaitu kes jangkitan di luar negara di samping empat kluster baharu iaitu Kurau (Pulau Pinang), Meranti (Wilayah Persekutuan Kuala Lumpur), Tawar (Kedah) dan terkini Muda (Kedah).

Daripada 20 kes baharu dilaporkan sehingga pukul 12.00 tengah hari Jumaat 14 Ogos, 13 kes adalah penularan dalam negara melibatkan warganegara Malaysia, iaitu Kluster Tawar Kedah (10 kes), Kluster Tawar Pulau Pinang (1 kes), Kluster Muda Kedah (1 kes) dan satu kes SARI (Jangkitan Pernafasan Akut Teruk).

Tujuh lagi adalah kes import (jangkitan di luar negara) , iaitu enam (6) melibatkan warganegara pulang dari Lubnan (3 kes), masing-masing satu dari Taiwan , Indonesia dan Yaman, sementara seorang bukan warganegara di Sarawak yang pulang dari Yaman.

COVID-19: Empat Kluster Baharu, Kes Aktif Meningkat 196

Oleh Melati Mohd Ariff

Berikut adalah rangkuman TERKINI mingguan mengenai COVID-19 dan perkara yang berkaitan di Malaysia serta di peringkat dunia dari 8 Ogos hingga pukul 7:30 mlm 14 Ogos.

Jumlah kes COVID-19 di Malaysia melepasi angka 9,000 sementara di peringkat global, kes wabak ini mengatasi 20 juta dengan lebih 700,000 kematian. Lebih 14 juta orang pesakit COVID-19 dilaporkan sembuh. Pandemik COVID-19 sudah merebak ke lebih 200 buah negara dan wilayah.

KUALA LUMPUR (Bernama) -- Kes baharu COVID-19 sepanjang rangkuman mingguan ini banyak melibatkan kes import iaitu kes jangkitan di luar negara di samping empat kluster baharu iaitu Kurau (Pulau Pinang), Meranti (Wilayah Persekutuan Kuala Lumpur), Tawar (Kedah) dan terkini Muda (Kedah).

Daripada 20 kes baharu dilaporkan sehingga pukul 12.00 tengah hari Jumaat 14 Ogos, 13 kes adalah penularan dalam negara melibatkan warganegara Malaysia, iaitu Kluster Tawar Kedah (10 kes), Kluster Tawar Pulau Pinang (1 kes), Kluster Muda Kedah (1 kes) dan satu kes SARI (Jangkitan Pernafasan Akut Teruk).

Tujuh lagi adalah kes import (jangkitan di luar negara) , iaitu enam (6) melibatkan warganegara pulang dari Lubnan (3 kes), masing-masing satu dari Taiwan , Indonesia dan Yaman, sementara seorang bukan warganegara di Sarawak yang pulang dari Yaman.

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

Embracing New Norms To Safeguard Against Pandemic

By Erda Khursyiah Basir

This article is in conjunction with the launch of the Embracing New Norms campaign by Prime Minister Tan Sri Muhyiddin Yassin in Pagoh, Johor, today.

KUALA LUMPUR (Bernama) – With the end of the COVID-19 pandemic nowhere in sight, the best thing for Malaysians to do to keep themselves safe is to mask up and carry a sanitiser with them when going out, in addition to washing hands regularly and observing physical distancing.

Most of them have been taking these precautions since the Movement Control Order (MCO) was enforced on March 18 to break the chain of COVID-19 infections.

While the public, in general, has been adapting to the new norms, certain quarters are still throwing caution to the wind, which is why the government, beginning Aug 1, decided to make it compulsory for everyone to wear a face mask when travelling in public transport and in congested public places.